Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023. (2023)
Attributed to:
Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2807/1560-7917.es.2023.28.21.2300116
PubMed Identifier: 37227299
Publication URI: http://europepmc.org/abstract/MED/37227299
Type: Journal Article/Review
Volume: 28
Parent Publication: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Issue: 21
ISSN: 1025-496X